141 related articles for article (PubMed ID: 872319)
1. Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.
Sellers TD; Bashore TM; Gallagher JJ
Circulation; 1977 Aug; 56(2):260-7. PubMed ID: 872319
[TBL] [Abstract][Full Text] [Related]
2. Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Merrill JJ; DeWeese G; Wharton JM
Am J Med; 1994 Jul; 97(1):25-8. PubMed ID: 8030653
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ
Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107
[TBL] [Abstract][Full Text] [Related]
4. Sinus bradycardia and atrial fibrillation associated with the Wolff-Parkinson-White syndrome.
Dreifus LS; Wellens HJ; Watanabe Y; Kimbiris D; Truex R
Am J Cardiol; 1976 Aug; 38(2):149-56. PubMed ID: 952259
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response.
Critelli G; Gallagher JJ; Perticone F; Coltorti F; Monda V; Condorelli M
Am Heart J; 1984 Oct; 108(4 Pt 1):905-9. PubMed ID: 6486001
[TBL] [Abstract][Full Text] [Related]
6. Intermittent Wolff-Parkinson-White syndrome due to phase 3 and phase 4 block: disappearance of rapid ventricular response during atrial fibrillation.
Fujiki A; Yoshida S; Tani M; Sasayama S
J Electrocardiol; 1988 Jan; 21(1):77-82. PubMed ID: 3351413
[TBL] [Abstract][Full Text] [Related]
7. Refractory periods of the accessory pathway in the Wolff-Parkinson-White syndrome.
Tonkin AM; Miller HC; Svenson RH; Wallace AG; Gallagher JJ
Circulation; 1975 Oct; 52(4):563-9. PubMed ID: 1157269
[TBL] [Abstract][Full Text] [Related]
8. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
[TBL] [Abstract][Full Text] [Related]
9. Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.
Wellens HJ; Durrer D
Am J Cardiol; 1974 Dec; 34(7):777-82. PubMed ID: 4432808
[No Abstract] [Full Text] [Related]
10. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
[TBL] [Abstract][Full Text] [Related]
11. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
Gulamhusein S; Ko P; Carruthers SG; Klein GJ
Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
[TBL] [Abstract][Full Text] [Related]
12. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Morady F; DiCarlo LA; Baerman JM; De Buitleir M
Pacing Clin Electrophysiol; 1987 May; 10(3 Pt 1):492-6. PubMed ID: 2439997
[TBL] [Abstract][Full Text] [Related]
13. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ
N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252
[TBL] [Abstract][Full Text] [Related]
14. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Inoue H; Zipes DP
Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
16. Prediction of a fatal atrial fibrillation in patients with asymptomatic Wolff-Parkinson-White pattern.
Fukatani M; Tanigawa M; Mori M; Konoe A; Kadena M; Shimizu A; Hashiba K
Jpn Circ J; 1990 Oct; 54(10):1331-9. PubMed ID: 2277412
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
[TBL] [Abstract][Full Text] [Related]
18. Pre-excited RR intervals during atrial fibrillation in the Wolff-Parkinson-White syndrome: influence of the atrioventricular node refractory period.
Fujimura O; Kuo CS; Smith BA
J Am Coll Cardiol; 1991 Dec; 18(7):1722-6. PubMed ID: 1960320
[TBL] [Abstract][Full Text] [Related]
19. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
20. Novel Assessment of Accessory Pathway Function in Patients with Wolff-Parkinson-White Syndrome.
Rigos LJ; Fishbein JS; Blaufox AD
Pediatr Cardiol; 2020 Aug; 41(6):1212-1219. PubMed ID: 32529357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
